Moreover, BRAFi significantly decreased the expression of HIF‐1α in D4M tumors, and the effect was maintained in combination with anti‐m‐VEGFA treatment but not after anti‐mVEGFA alone, indicating that BRAF inhibition is critical for abrogating tumor hypoxia (Fig. S2). Here, VEGFA is linked to neoplasm.